Omeros reported $29.67M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acelrx Pharmaceuticals ACRX:US $ -342000 890K
Adma Biologics ADMA:US $ 3.66M 0.15M
Aerie Pharmaceuticals AERI:US $ 23.06M 85.54M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Dynavax Technologies DVAX:US $ 74.03M 47.03M
Gilead Sciences GILD:US $ 5166M 549M
Heron Therapeutics HRTX:US $ 12.1M 2.39M
Insmed INSM:US $ 40.92M 1.92M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
Knight Therapeutics Inc GUD:CN C$ 32.48M 4.28M
MacroGenics MGNX:US 11.05M 2.15M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Pfizer PFE:US $ 15651M 1627M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
United Therapeutics UTHR:US $ 436M 55.4M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M